{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:35:21Z","timestamp":1772591721205,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":5236,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1046\/j.0022-202x.2001.01427.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T05:59:03Z","timestamp":1047448743000},"page":"371-374","source":"Crossref","is-referenced-by-count":36,"title":["Perilesional Injection of r-GM-CSF in Patients with Cutaneous Melanoma Metastases"],"prefix":"10.1016","volume":"117","author":[{"given":"Christoph","family":"Hoeller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Heere-Ress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Pustelnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Mossbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermine","family":"Schlagbauer-Wadl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Pehamberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0010","first-page":"2316","article-title":"Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases","volume":"5","author":"Anderson","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0015","first-page":"2191","article-title":"Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells","volume":"56","author":"Armstrong","year":"1996","journal-title":"Cancer Res"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0020","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/1097-0142(19920315)69:6<1377::AID-CNCR2820690613>3.0.CO;2-N","article-title":"Regression of primary melanoma with metastases","volume":"69","author":"Avril","year":"1992","journal-title":"Cancer"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0025","series-title":"Cutaneous Melanoma","first-page":"165","article-title":"An analysis of prognostic factors in 8500 patients with cutaneous melanoma","author":"Balch","year":"1992"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2559.1992.tb00988.x","article-title":"Histological regression in primary cutaneous melanoma: recognition, prevalence, and significance","volume":"20","author":"Blessing","year":"1992","journal-title":"Histopathology"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0035","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2345::AID-CNCR8>3.0.CO;2-K","article-title":"Prolonged survival of 2 years or longer for patients with disseminated melanoma","volume":"79","author":"Brand","year":"1997","journal-title":"Cancer"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0040","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte macrophage colony stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0045","series-title":"Cutaneous Melanoma","first-page":"144","article-title":"Immune responses to melanoma","author":"Itoh","year":"1992"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00002371-199903000-00008","article-title":"Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma","volume":"22","author":"Leong","year":"1999","journal-title":"J Immunother"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0167-5699(92)90008-U","article-title":"Origin and function of tumor associated macrophages","volume":"67","author":"Mantovani","year":"1992","journal-title":"Immunol Today"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0060","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.cgt.7700066","article-title":"Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma","volume":"6","author":"Mastrangelo","year":"1998","journal-title":"Cancer Gene Ther"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0167-5699(93)90051-L","article-title":"Cancer vaccines","volume":"14","author":"Pardoll","year":"1993","journal-title":"Immunol Today"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00002371-199805000-00007","article-title":"Cytokine gene therapy or infusion as treatment for solid human cancer","volume":"21","author":"Robinson","year":"1998","journal-title":"J Immunother"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0075","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.3489291","article-title":"A new approach to the adoptive immunotherapy of cancer with tumor infiltrating lymphocytes","volume":"223","author":"Rosenberg","year":"1986","journal-title":"Science"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00008390-199606000-00008","article-title":"Clinical response and lymphoid infiltrates in metastatic melanoma following treatment with intralesional GM-CSF","volume":"6","author":"Si","year":"1996","journal-title":"Melanoma Res"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0085","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.95.22.13141","article-title":"Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma","volume":"95","author":"Soiffer","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0090","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1200\/JCO.2000.18.8.1614","article-title":"Adjuvant therapy of stage III and IV malignant melanoma using granulocyte. macrophage colony. stimulating factor","volume":"18","author":"Spitler","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.0022-202x.2001.01427.x_bb0095","series-title":"Handbook for Reporting Results of Cancer Treatment","author":"WHO","year":"1979"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15413387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15413387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T02:59:26Z","timestamp":1555037966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15413387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0022202X15413387"],"URL":"https:\/\/doi.org\/10.1046\/j.0022-202x.2001.01427.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}